BLISS: quantitative and versatile genome-wide profiling of DNA breaks in situ

Winston X Yan,Reza Mirzazadeh,Silvano Garnerone,David Arthur Scott,Martin W. Schneider,Tomasz Kallas,Joaquin Custodio,Erik Wernersson,Linyi Gao,Yinqing Li,Yana Federova,Bernd Zetsche,Feng Zhang,Magda Bienko,Nicola Crosetto
DOI: https://doi.org/10.1101/091629
2016-01-01
bioRxiv
Abstract:We present a method for genome-wide DNA double-strand Breaks (DSBs) Labeling In Situ and Sequencing (BLISS) which, compared to existing methods, introduces several key features: 1) high efficiency and low input requirement by in situ DSB labeling in cells or tissue sections directly on a solid surface; 2) easy scalability by performing in situ reactions in multi-well plates; 3) high sensitivity by linearly amplifying tagged DSBs using in vitro transcription; and 4) accurate DSB quantification and control of PCR biases by using unique molecular identifiers. We demonstrate the ability to use BLISS to quantify natural and drug-induced DSBs in low-input samples of cancer cells, primary mouse embryonic stem cells, and mouse liver tissue sections. Finally, we applied BLISS to compare the specificity of CRISPR-associated RNA-guided endonucleases Cas9 and Cpf1, and found that Cpf1 has higher specificity than Cas9. These results establish BLISS as a versatile, sensitive, and efficient method for genome- wide DSB mapping in many applications.
What problem does this paper attempt to address?